Please login to the form below

Not currently logged in
Email:
Password:

Sage Therapeutics

This page shows the latest Sage Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Sage’s postpartum depression treatment Zulresso gains US approval

Sage’s postpartum depression treatment Zulresso gains US approval

First approval of its kind. The FDA has approved Sage Therapeutics’ treatment for postpartum depression, Zulresso (brexanolone). ... The approval also represents the first product on the market for Sage Therapeutics.

Latest news

  • Sage raises $575m ahead of FDA review date for Zulresso Sage raises $575m ahead of FDA review date for Zulresso

    Company should get verdict by 19 March. In just under three weeks, Sage Therapeutics should hear back from the FDA on its filing for new antidepressant Zulresso, and the company has ... Sage already has a positive FDA advisory committee meeting in hand

  • Sage surges after depression drug gets rapid path to approval Sage surges after depression drug gets rapid path to approval

    The FDA has given its blessing to an expedited development route for Sage Therapeutics’ depression pill SAGE-217, upgrading its ongoing study to a pivotal trial. ... The excitement behind the drugs is that they seem to show a clinical effect quickly,

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Shires's Jeffrey Jonas to lead Sage Shires's Jeffrey Jonas to lead Sage

    CNS appoints CEO alongside new CMO and CFO. Sage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO. ... The changes come two years after the formation of the central nervous system (CNS)

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics